To provide recommendations to the Board and the Registrar on matters relating to pharmacy legislation and policy review.
Justin Thind (Chair)
Andrea Silver (Vice-Chair)
Christine Paramonczyk (staff resource)
Number of Meetings: 4
Accomplishments of the Year
- Over the past year, the Legislation Review Committee recommended the following changes to policy, bylaws, fees, and Standards of Practice1:
|Health Professions Act (HPA) Bylaws||
Pharmacy Operations and Drug Scheduling Act (PODSA) Bylaws
|Professional Practice Policies (PPP)||
|Drug Schedules Regulation (DSR)||
1 Please note that this annual report only includes amendments that obtained LRC approval. In 2020, due to need to address the COVID-19 epidemic in an expedited fashion, there were multiple bylaw and policy amendments that proceeded for Board approval without first being approved by the LRC. That process was enabled by the following March 2020 Board decision: “Approve all legislative changes to temporarily bypass the Legislation Review Committee and to go directly to the Board for approval amid COVID-19 pandemic.”
Goals for Next Fiscal Year
- Initiate scoping a comprehensive review and reform of legislative requirements under the Standards of Practice.
- Review and analyze amendments to the Health Professions Act, anticipated to be released by the provincial government. In addition, develop bylaw amendments, to implement the Health Professions Act changes.
- Implementation of bylaws adopting the National Association of Pharmacy Regulatory Authorities Model Standards for Sterile Compounding.